ADC THERAPEUTICS SA (ADCT:NYSE)
$1.06 0.02 (1.9231%)
Analysed ADC THERAPEUTICS SA (ADCT:NYSE) News Sources
ADC Therapeutics Announces Strategic Reorganization to Support ZYNLONTA® Growth Opportunities and Regulatory Priorities
24-06-2026
yahoo.com
ADC Therapeutics To Cut About 17% Of Its Staff – A Look At Some Key Details
24-06-2026
stocktwits.com
ADC Therapeutics (ADCT) Stock Fair Value Falls After LOTIS 5 Reshapes Analyst Views
27-06-2026
yahoo.com
ADC Therapeutics Announces Completion of Enrollment in LOTIS-7 Phase 1b ZYNLONTA® Combination Trial
30-06-2026
yahoo.com
ADC Therapeutics Announces New Employee Inducement Grant
01-07-2026
yahoo.com
ADC Therapeutics SA (ADCT) Reports Q2 Loss, Lags Revenue Estimates
13-08-2026
yahoo.com
ADC Therapeutics Q2 Earnings Call Highlights
13-08-2026
marketbeat.com
ADC Therapeutics SA (ADCT) (Q2 2026) Earnings Call Highlights: Navigating Regulatory Hurdles ...
13-08-2026
yahoo.com
ADC Therapeutics (ADCT) Stock Fair Value Falls After LOTIS 5 Reshapes Zynlonta Outlook
16-08-2026
yahoo.com
ADC Therapeutics (ADCT) Q2 2026 Earnings Call Transcript
20-08-2026
fool.com
What is the current price of ADC THERAPEUTICS SA (ADCT:NYSE)?
The current price of ADC THERAPEUTICS SA (ADCT:NYSE) is $1.06.
ADC THERAPEUTICS SA (ADCT:NYSE) absolute price change since previous trading day?
The absolute price change of ADC THERAPEUTICS SA (ADCT:NYSE) since the previous trading day is $0.02.
ADC THERAPEUTICS SA (ADCT:NYSE) percentage price change since previous trading day?
The percentage price change of ADC THERAPEUTICS SA (ADCT:NYSE) since the previous trading day is 1.9231%.
What is the most recent average sentiment score for ADC THERAPEUTICS SA (ADCT:NYSE)?
The most recent average sentiment score for ADC THERAPEUTICS SA (ADCT:NYSE) is 57 out of 100.
What is the most recent average sentiment for ADC THERAPEUTICS SA (ADCT:NYSE)?
The most recent sentiment for ADC THERAPEUTICS SA (ADCT:NYSE) is .
SEC-8K** Filing Available For ADC THERAPEUTICS SA (ADCT:NYSE)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.